SI-BONE, Inc (SIBN)

Investors are facing a confusing environment, with long- and short-term signals sending different messages. Inflation remains stubbornly high, above an 8% annualized rate, and the Federal Reserve has made it clear that additional interest rate hikes are in the offing. Stocks are well off their highs, and despite last Friday's gains, the S&P 500 and the Nasdaq posted their sixth consecutive weekly loss. But there are positives, too. The 1Q22 earnings season gave an upbeat vibe, as more than three

Si-Bone (SIBN) delivered earnings and revenue surprises of -20.93% and 0.31%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

SANTA CLARA, Calif., May 09, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter ended March 31, 2022. Recent Highlights Worldwide revenue of $22.4 million for the first quarter 2022, representing a 10% increase over the corresponding period in 2021U.S. revenue of $20.4 million for the first quarter 2022, representing a 9% increase over the corres

Companies Reporting Before The Bell • Atlantica Sustainable (NASDAQ:AY) is likely to report quarterly loss at $0.08 ...

SI-BONE (NASDAQ:SIBN) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know ...

ViewRay (VRAY) delivered earnings and revenue surprises of 12.50% and 13.55%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Nevro (NVRO) delivered earnings and revenue surprises of 11.71% and 2.02%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in SI-BONE Inc (SIBN), where a total volume of 1,380 contracts has been traded thus far today, a contract volume which is representative of approximately 138,000 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 62.3% of SIBN's average daily trading volume over the past month, of 221,525 shares..

Si-Bone (SIBN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

In trading on Wednesday, the iShares US Medical Devices ETF is outperforming other ETFs, up about 2.6% on the day. Components of that ETF showing particular strength include shares of Si-bone, up about 4.5% and shares of Intuitive Surgical, up about 3.8% on the day.

SANTA CLARA, Calif., April 19, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN) a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the Centers for Medicare and Medicaid Services (CMS) has proposed a New Technology Add-on Payment (NTAP) for the iFuse Bedrock Granite™ implant. The Granite implant is intended to provide sacroiliac fusion and sacropelvic fixation as a foundational element for segmental s

SANTA CLARA, Calif., April 18, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming 2022 Bank of America Healthcare Conference in Las Vegas. Management will be hosting a fireside chat presentation on Wednesday, May 11th, 2022, at 12:40 p.m. Pacific Time / 3:40 p.m. Eastern Time. A live webcast of each event, as well as an arc

SANTA CLARA, Calif., April 18, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the first quarter of 2022 after market close on Monday, May 9, 2022. The company’s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in SI-BONE Inc (SIBN), where a total of 1,167 contracts have traded so far, representing approximately 116,700 underlying shares. That amounts to about 41.9% of SIBN's average daily trading volume over the past month of 278,755 shares..

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares US.

Chelsea soccer team owner Roman Abramovich will face an asset freeze and travel ban, but the top-ranked club will be allowed to continue football related activities.

Russian markets have been closed for four straight days after the country's invasion of Ukraine.

SI-BONE (NASDAQ:SIBN) reported its Q4 earnings results on Monday, February 28, 2022 at 04:00 PM. Here's what investors need to ...

SANTA CLARA, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter and full year ended December 31, 2021. Recent Highlights Worldwide revenue of $25.2 million for the fourth quarter 2021 and $90.2 million for the full year 2021, representing an increase of 14% and 23%, respectively, over the corresponding periods in 2020U.S. revenue

Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its ...

On Friday, 209 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Meta ...

SANTA CLARA, Calif., Feb. 01, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the fourth quarter and full year 2021 after market close on Monday, February 28, 2022. The company’s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Investors interested in listening to the co

Russian stocks crashed and the ruble sank to its lowest level in more than a year, as investors feared the triggering of sanctions if the country invades Ukraine.

Preliminary 2021 revenue of $89.8-90.1 million represents growth of 22%-23%SANTA CLARA, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN) (“SI-BONE” or the “Company”), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced its preliminary and unaudited revenue for fourth quarter and full year 2021. Preliminary and unaudited revenue for fourth quarter 2021 is expected to be in the range of $24.9-$25.2 million, refle

SI-BONE, Inc. ( NASDAQ:SIBN ) shareholders should be happy to see the share price up 18% in the last month. But in...

SANTA CLARA, Calif., Dec. 27, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced management is scheduled to participate in the following investor conference: 24th Annual Needham Virtual Growth Conference on Wednesday, January 12, 2022 at 5:00 p.m. Eastern Time / 2:00 p.m. Pacific Time. Interested parties may access a live and archived webcast of the presen

Investment company Usgi Emerging Europe Fund (Current Portfolio) buys PJSC Lukoil, Rosneft Oil Co, Mining and Metallurgical Company NORILSK NICKEL PJ, Gazprom Neft PJSC, Novolipetsk Steel PJSC, sells Tatneft PJSC, TCS Group Holding PLC, EVRAZ PLC, Detskymir PJSC, Sistema PJSFC during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Usgi Emerging Europe Fund.

New York, NY, based Investment company Orbimed Advisors Llc (Current Portfolio) buys Adagio Therapeutics Inc, Zimmer Biomet Holdings Inc, Biogen Inc, HCA Healthcare Inc, Erasca Inc, sells Prelude Therapeutics Inc, Aurinia Pharmaceuticals Inc, Ascendis Pharma A/S, Natera Inc, Anthem Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Orbimed Advisors Llc.

Investment company MainStay VP Small Cap Growth Portfolio (Current Portfolio) buys Option Care Health Inc, Leslies Inc, Kratos Defense & Security Solutions Inc, 908 Devices Inc, SelectQuote Inc, sells Globant SA, Asana Inc, The Hain Celestial Group Inc, SiTime Corp, Vroom Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, MainStay VP Small Cap Growth Portfolio.